NASH
-
Conshohocken-based Madrigal Pharmaceuticals Launches Groundbreaking NASH Drug, Rezdiffra
In the less than two months since becoming the first drug developer to receive Food and Drug Administration clearance for…
-
All Eyes Are on Madrigal Pharmaceuticals as FDA’s Decision Draws Closer
Later this week, the U.S. Food and Drug Administration is expected to make a decision on Madrigal Pharmaceuticals’ experimental NASH…
-
Madrigal Pharmaceuticals Sells $500M in Stocks in Prep for FDA Approval
Conshohocken-based Madrigal Pharmaceuticals is in a flurry of activity as it prepares for the potential launch of its NASH drug…
-
Conshohocken-Based Madrigal’s Liver Disease Treatment Gets Priority Review by FDA
A Conshohocken-based pharmaceutical company’s treatment for nonalcoholic steatoheptatitis (NASH) a severe form of liver disease, is getting priority review by…
-
Montgomery County Pharma Company Aims to Have First FDA-Approved Drug for This Silent Disease
Currently there is no U.S. Food and Drug Administration-approved medicine for nonalcoholic steatohepatitis, also referred to as NASH. NASH is…
-
West Conshohocken Is Home to One of Best-paying Biopharma Companies in Country
One Montgomery County company found its place on the list of seven best-paying biopharma companies in the nation where workers…
-
Conshohocken-based Madrigal Pharmaceuticals’ Shares Skyrocket Following Liver Disease Clinical Trial
Conshohocken-based Madrigal Pharmaceuticals saw its shares leap in value after the company reported additional positive late-stage clinical trial data for…
-
Stock price surges for small West Conshohcken drug company
Madrigal Pharmaceuticals, West Conshohocken, has experienced a rapid rise in its stock price and market capitalization, which at the start of…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
